Daniel (Donny) Oliver (@celloradonc) 's Twitter Profile
Daniel (Donny) Oliver

@celloradonc

Radiation Oncologist (Brain, Spine, Metastatic Disease) at Moffitt Cancer Center @MoffittNews. @NDSS Dad. Go @ATLHawks

ID: 1174296463087681536

calendar_today18-09-2019 12:18:09

179 Tweet

257 Followers

540 Following

World Down Syndrome Day (@worlddsday) 's Twitter Profile Photo

We are delighted to support the CoorDown international awareness campaign for #WorldDownSyndromeDay 2024. #AssumeThatICan #WDSD24 #EndTheStereotypes youtu.be/9HpLhxMFJR8?si…

PDBrown (@pdbrownonc) 's Twitter Profile Photo

METIS positive randomized trial! Met Primary Endpoint Tumor Treatment fields significantly delay time to intracranial progression novocure.com/metis-phase-3-…

METIS positive randomized trial!
Met Primary Endpoint
Tumor Treatment fields significantly delay time to intracranial progression
novocure.com/metis-phase-3-…
Lea Alhilali, MD (@teachplaygrub) 's Twitter Profile Photo

If you aren’t cheating, you aren’t trying! Are you looking at MRIs? Feeling some confusion about the diffusion? Feel impaired when it comes to the FLAIR? Wish you could cheat a little? Here’s a little cheat sheet on all the sequences you NEED to know if you are looking at

If you aren’t cheating, you aren’t trying!

Are you looking at MRIs?

Feeling some confusion about the diffusion?

Feel impaired when it comes to the FLAIR?

Wish you could cheat a little?

Here’s a little cheat sheet on all the sequences you NEED to know if you are looking at
Eric Topol (@erictopol) 's Twitter Profile Photo

Gliobastomas are among the most aggressive and fatal cancers. After marked success treating 10 dogs, a unique IV "onionized" mRNA/nanoparticle individualized vaccine induced a striking anti-tumor immune response cell.com/cell/abstract/… Cell FLORIDA

Gliobastomas are among the most aggressive and fatal cancers. After marked success treating 10 dogs, a unique IV "onionized" mRNA/nanoparticle individualized vaccine induced a striking anti-tumor immune response
cell.com/cell/abstract/… <a href="/CellCellPress/">Cell</a>  <a href="/UF/">FLORIDA</a>
Jay Handlin (@jayhandlin) 's Twitter Profile Photo

For the first time, this is what a Master’s degree looks like. Today, my daughter #RachelHandlin became the 1st person with #Downsyndrome to earn a graduate degree. In the world. Ever. Rachel says: “I won’t be the last.” CalArts BFA 2020. Pratt Institute MFA 2024. Legend.

For the first time, this is what a Master’s degree looks like.

Today, my daughter #RachelHandlin became the 1st person with #Downsyndrome to earn a graduate degree.

In the world.

Ever.

Rachel says: “I won’t be the last.”

<a href="/CalArts/">CalArts</a> BFA 2020.

<a href="/PrattInstitute/">Pratt Institute</a> MFA 2024.

Legend.
James Caudell (@jjcaudell) 's Twitter Profile Photo

We're so busy that we have opened another HN rad onc position Moffitt Cancer Center. If interested in joining at team of 4 HN rad oncs, including me, Dr. M Echevarria, George Q. Yang, MD, and soon Niema Razavian, MD, send me your CV.

Simon Lo (@simonlo21054188) 's Twitter Profile Photo

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology ⁦ASTRO⁩ ⁦RANZCR Rad Oncology⁩ ⁦The Royal College of Radiologists⁩ ⁦ESTRO⁩ ⁦CARO-ACRO⁩ practicalradonc.org/article/S1879-…

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At #ASCO24, Kamran Ahmed, MD (Kamran Ahmed) presented the latest in metastatic triple negative breast cancer with brain metastases. #MoffittASCO24 Learn more: bit.ly/3yBeMqZ ASCO

Prostate Cancer Foundation (@pcfnews) 's Twitter Profile Photo

Swing for a cure! Today we are featuring Dr. Kosj Yamoah MD, PhD Kosj is a 2014 PCF-Young Investigator & clinician scientist. He studies biological factors related to increased prostate cancer risk & mortality in men of African origin. Thank you for your work and joining our team!

Swing for a cure! Today we are featuring Dr. <a href="/KOSJ12/">Kosj Yamoah MD, PhD</a>

Kosj is a 2014 PCF-Young Investigator &amp; clinician scientist. He studies biological factors related to increased prostate cancer risk &amp; mortality in men of African origin. 

Thank you for your work and joining our team!
Johns Hopkins University PCCM Fellowship (@jhupccmfellows) 's Twitter Profile Photo

Our 2023-2024 Faculty Teaching Award is Dr. Niru Putcha. Our fellows describe Dr. Putcha as having "clinical mastery combined with a patience and compassion for learners that cultivates a safe, enjoyable, and productive learning environment"

Our 2023-2024 Faculty Teaching Award is Dr. Niru Putcha. Our fellows describe Dr. Putcha as having "clinical mastery combined with a patience and compassion for learners that cultivates a safe, enjoyable, and productive learning environment"
MJ Lim-Fat (@mjlimfat) 's Twitter Profile Photo

We report on an oncogenic KRAS p.Q61R mutation in a noncerebellar PA with an impressive objective response to MEK inhibition Katrina Roberto, with patient permission. JCO Precision Oncology ascopubs.org/doi/10.1200/PO…

We report on an oncogenic KRAS p.Q61R mutation in a noncerebellar PA with an impressive objective response to MEK inhibition <a href="/kaetroberto/">Katrina Roberto</a>, with patient permission. <a href="/JCOPO_ASCO/">JCO Precision Oncology</a> 
ascopubs.org/doi/10.1200/PO…
Dr. David Palma (@drdavidpalma) 's Twitter Profile Photo

Hot off the press in IJROBP - The Red Journal: the ARREST phase I trial of SABR in poly-metastatic disease, led by Glenn Bauman, MD & Tim Nguyen Average number of lesions = 16 Dose safely escalated to 30 Gy in 5 fractions. sciencedirect.com/science/articl… The phase II/III RCT ARREST2 is underway!

Hot off the press in <a href="/IJROBP/">IJROBP - The Red Journal</a>: the ARREST phase I trial of SABR in poly-metastatic disease, led by <a href="/lhscradonc/">Glenn Bauman, MD</a> &amp; <a href="/TimkWin/">Tim Nguyen</a> 

Average number of lesions = 16 
Dose safely escalated to 30 Gy in 5 fractions. 

sciencedirect.com/science/articl…

The phase II/III RCT ARREST2 is underway!
Applied Radiation Oncology (@applied_radonc) 's Twitter Profile Photo

Case Report: Role of Boswellia Serrata in Management of CNS Radiation Necrosis After Radiosurgery for Brain Metastases 🔗 bit.ly/48mCy6n #RadOnc #RadOncEd #MedEd #CaseReport

Case Report: Role of Boswellia Serrata in Management of CNS Radiation Necrosis After Radiosurgery for Brain Metastases

🔗 bit.ly/48mCy6n

#RadOnc #RadOncEd #MedEd #CaseReport